TY  - JOUR
AU  - Cámara, Rosa
AU  - Venegas, Eva
AU  - García-Arnés, Juan Antonio
AU  - Cordido, Fernando
AU  - Aller, Javier
AU  - Samaniego, M Luz
AU  - Mir, Nuria
AU  - Sánchez-Cenizo, Laura
PY  - 2019
DO  - 10.1007/s11102-019-00943-1
UR  - http://hdl.handle.net/10668/13557
T2  - Pituitary
AB  - The burden of chronic daily subcutaneous administration of pegvisomant on adherence has not been previously studied. This study was aimed to determine the adherence to pegvisomant treatment in acromegaly patients in the real-world clinical practice...
LA  - en
KW  - Acromegaly
KW  - Medication adherence
KW  - Medication errors
KW  - Patient compliance
KW  - Patient satisfaction
KW  - Pegvisomant
KW  - Acromegaly
KW  - Adult
KW  - Aged
KW  - Cross-Sectional Studies
KW  - Female
KW  - Human Growth Hormone
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multicenter Studies as Topic
KW  - Spain
KW  - Surveys and Questionnaires
TI  - Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study.
TY  - research article
VL  - 22
ER  -